A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...

Goldman Sachs has initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) based on multi-blockbuster, first-to-market ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

"This could be a game-changer for treating complex conditions where targeting multiple pathways is beneficial, such as cancer ...

A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...

Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...

It all started in the lab. Two Boston University doctoral students, Joshua McGee and Jack Kirsch, were creating and testing ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

RNAConnect, a pioneering life science reagent company, today announced new distribution agreements with CliniSciences, 2BScientific, and Dakewe Biotech. These partnerships mark a significant milestone ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...

Check the time stamp on this data. Updated AI-Generated Signals for Avidity Biosciences Inc. (RNA) available here: RNA.

Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the ...